ISCT 2020 | Respiratory pathology of COVID-19 and potential for MSCs

Mauro Krampera, MD, PhD, of the University of Verona, Verona, Italy, discusses the pathogenesis of COVID-19 and the potential benefit of administrating mesenchymal stromal cells (MSCs) based on outcomes of patients with inflammatory disorders treated using this approach. This interview was recorded via an online conference call with The Video Journal of Regenerative Medicine (VJRegenMed).